The state has acknowledged it will run short of its execution drug next year. Ohio has also faced criticism of its execution methods from a federal judge, whose ruling has put executions in the state on hold.
The prison system has suggested that the state’s untested backup method, which involves intramuscular injections that could cause vomiting or convulsions, may be used as early as next spring.
Ohio currently uses a single dose of the anesthetic pentobarbital to execute inmates, but only has enough in stock to last through Feb. 2012, according to the report.
Related Articles on Anesthesia:
Drug Manufacturer Teva Ceases Propofol Production Following $500M Award to Hep C Patient
Morphine Could Be Delivered More Easily Through New “Pressurized Olfactory Device”
Cholesterol Lowering Drug Reduces Spinal Cord Injury From Surgery
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
